APRE
Aprea Therapeutics, Inc.
+0.01 (+1.29%)0.74USD70.1K成交股數9.3M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-16 | 06-17 | HENNEMAN JOHN B III | Director | A 獲配股票 | 3.1K | – | – | 13.4K | SEC |
| 2026-06-16 | 06-17 | Pamukcu Rifat | Director | A 獲配股票 | 3.1K | – | – | 8.6K | SEC |
| 2026-06-16 | 06-17 | Seizinger Bernd R. | Director | A 獲配股票 | 3.1K | – | – | 48.9K | SEC |
| 2026-06-16 | 06-17 | BIZZARI JEAN-PIERRE | Director | A 獲配股票 | 3.1K | – | – | 4.2K | SEC |
| 2026-06-16 | 06-17 | Peters Richard | Director | A 獲配股票 | 3.1K | – | – | 6.3K | SEC |
| 2026-06-16 | 06-17 | Duey Marc | Director | A 獲配股票 | 3.1K | – | – | 259K | SEC |
| 2026-06-16 | 06-17 | Gruia Gabriela | Director | A 獲配股票 | 3.1K | – | – | 4.2K | SEC |
| 2026-06-16 | 06-17 | Grissinger Michael | Director | A 獲配股票 | 3.1K | – | – | 6.0K | SEC |
| 2026-03-12 | 03-16 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A 獲配股票 | 10.1K | – | – | 43.5K | SEC |
| 2026-03-12 | 03-16 | Gilad Oren | President/CEO | A 獲配股票 | 20.2K | – | – | 394K | SEC |
| 2026-01-30 | 02-02 | Gilad Oren | President/CEO | P 公開市場買進 | 28.1K | 0.89 | 25K | 374K | SEC |
| 2026-01-30 | 02-02 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P 公開市場買進 | 5.7K | 0.89 | 5K | 33.4K | SEC |
| 2025-12-10 | 12-11 | Duey Marc | Director | P 公開市場買進 | 21.5K | 1.17 | 25K | 256K | SEC |
| 2025-12-10 | 12-11 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P 公開市場買進 | 5.0K | 1.17 | 6K | 27.7K | SEC |
| 2025-06-05 | 06-09 | Grissinger Michael | Director | A 獲配股票 | 1.0K | – | – | 2.9K | SEC |
| 2025-06-05 | 06-09 | Seizinger Bernd R. | Director | A 獲配股票 | 1.0K | – | – | 45.8K | SEC |
| 2025-06-05 | 06-09 | Duey Marc | Director | A 獲配股票 | 1.0K | – | – | 235K | SEC |
| 2025-06-05 | 06-09 | HENNEMAN JOHN B III | Director | A 獲配股票 | 1.0K | – | – | 10.2K | SEC |
| 2025-06-05 | 06-09 | BIZZARI JEAN-PIERRE | Director | A 獲配股票 | 1.0K | – | – | 1.0K | SEC |
| 2025-06-05 | 06-09 | Pamukcu Rifat | Director | A 獲配股票 | 1.0K | – | – | 5.4K | SEC |
| 2025-06-05 | 06-09 | Gruia Gabriela | Director | A 獲配股票 | 1.0K | – | – | 1.0K | SEC |
| 2025-06-05 | 06-09 | Peters Richard | Director | A 獲配股票 | 1.0K | – | – | 3.1K | SEC |
| 2025-04-03 | 04-04 | Gilad Oren | President/CEO | P 公開市場買進 | 3.0K | 1.87 | 6K | 343K | SEC |
| 2025-04-03 | 04-04 | Gilad Oren | President/CEO | P 公開市場買進 | 2.5K | 1.80 | 4K | 346K | SEC |
| 2025-03-27 | 03-31 | Gilad Oren | President/CEO | A 獲配股票 | 6.7K | – | – | 340K | SEC |
| 2025-03-27 | 03-31 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A 獲配股票 | 3.4K | – | – | 22.7K | SEC |
| 2024-10-23 | 10-24 | Gilad Oren | President/CEO | P 公開市場買進 | 500 | 3.92 | 2K | 333K | SEC |
| 2024-10-18 | 10-25 | Duey Marc | Director | S 公開市場賣出 | 6.5K | 4.58 | 30K | 234K | SEC |
| 2024-10-16 | 10-17 | Duey Marc | Director | P 公開市場買進 | 30.0K | 4.39 | 132K | 240K | SEC |
| 2024-10-15 | 10-16 | Gilad Oren | President/CEO | P 公開市場買進 | 250 | 2.90 | 725.00 | 333K | SEC |
| 2024-10-14 | 10-16 | Duey Marc | Director | P 公開市場買進 | 190 | 2.58 | 490.20 | 210K | SEC |
| 2024-10-14 | 10-15 | Gilad Oren | President/CEO | P 公開市場買進 | 1.0K | 2.59 | 3K | 333K | SEC |
| 2024-10-11 | 10-16 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P 公開市場買進 | 50 | 2.46 | 123.00 | 19.4K | SEC |
| 2024-10-11 | 10-15 | Seizinger Bernd R. | Director | P 公開市場買進 | 10.0K | 2.68 | 27K | 44.7K | SEC |
| 2024-10-10 | 10-15 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P 公開市場買進 | 450 | 2.61 | 1K | 19.3K | SEC |
| 2024-10-10 | 10-15 | Gilad Oren | President/CEO | P 公開市場買進 | 150 | 2.54 | 381.00 | 332K | SEC |
| 2024-06-20 | 06-21 | Duey Marc | Director | A 獲配股票 | 1.0K | – | – | 210K | SEC |
| 2024-06-20 | 06-21 | Grissinger Michael | Director | A 獲配股票 | 1.0K | – | – | 1.8K | SEC |
| 2024-06-20 | 06-21 | Seizinger Bernd R. | Director | A 獲配股票 | 1.0K | – | – | 34.7K | SEC |
| 2024-06-20 | 06-21 | Pamukcu Rifat | Director | A 獲配股票 | 1.0K | – | – | 4.4K | SEC |
| 2024-06-20 | 06-21 | Peters Richard | Director | A 獲配股票 | 1.0K | – | – | 2.1K | SEC |
| 2024-06-20 | 06-21 | HENNEMAN JOHN B III | Director | A 獲配股票 | 1.0K | – | – | 9.2K | SEC |
| 2024-05-01 | 05-02 | Mirza Nadeem Q. | Chief Medical Officer | A 獲配股票 | 6.7K | – | – | 6.7K | SEC |
| 2024-03-28 | 03-28 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A 獲配股票 | 3.4K | – | – | 18.9K | SEC |
| 2024-03-28 | 03-28 | Gilad Oren | President, CEO | A 獲配股票 | 6.7K | – | – | 331K | SEC |
| 2024-03-13 | 03-14 | Gilad Oren | President, CEO | P 公開市場買進 | 2.0K | 7.29 | 15K | 325K | SEC |
| 2024-03-13 | 03-14 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P 公開市場買進 | 1.0K | 7.29 | 7K | 15.5K | SEC |
| 2024-03-13 | 03-14 | Seizinger Bernd R. | Director | P 公開市場買進 | 6.9K | 7.29 | 50K | 33.7K | SEC |
| 2024-03-13 | 03-14 | HENNEMAN JOHN B III | Director | P 公開市場買進 | 6.9K | 7.29 | 50K | 8.1K | SEC |
| 2023-08-23 | 08-24 | Pamukcu Rifat | Director | A 獲配股票 | 500 | – | – | 3.4K | SEC |
| 2023-08-23 | 08-24 | Grissinger Michael | Director | A 獲配股票 | 500 | – | – | 799 | SEC |
| 2023-08-23 | 08-24 | HENNEMAN JOHN B III | Director | A 獲配股票 | 500 | – | – | 1.3K | SEC |
| 2023-08-23 | 08-24 | Peters Richard | Director | A 獲配股票 | 500 | – | – | 1.0K | SEC |
| 2023-08-23 | 08-24 | Duey Marc | Director | A 獲配股票 | 500 | – | – | 209K | SEC |
| 2023-08-23 | 08-24 | Seizinger Bernd R. | Director | A 獲配股票 | 500 | – | – | 26.8K | SEC |
| 2023-06-07 | 06-08 | Seizinger Bernd R. | Director | P 公開市場買進 | 6.0K | 3.68 | 22K | 26.3K | SEC |
| 2023-06-06 | 06-08 | Seizinger Bernd R. | Director | P 公開市場買進 | 4.1K | 3.63 | 15K | 20.3K | SEC |
| 2023-03-09 | 03-13 | Gilad Oren | President, CEO | A 獲配股票 | 4.0K | – | – | 323K | SEC |
| 2023-02-27 | 02-27 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A 獲配股票 | 1.0K | 5.25 | 5K | 14.5K | SEC |
| 2023-01-30 | 01-30 | Hamill John P. | SrVP/CFO/Prin. Fin&Acctg. Off | A 獲配股票 | 270K | – | – | 270K | SEC |
| 2022-08-23 | 08-24 | Pamukcu Rifat | Director | C 轉換 | 49.3K | – | – | 57.1K | SEC |
| 2022-08-23 | 08-24 | Pamukcu Rifat | Director | C 轉換 | 272K | – | – | 14.1K | SEC |
| 2022-08-23 | 08-24 | Duey Marc | Director | C 轉換 | 11.6K | – | – | 602 | SEC |
| 2022-08-23 | 08-24 | Duey Marc | Director | C 轉換 | 4.0M | – | – | 4.2M | SEC |
| 2022-08-23 | 03-13 | Gilad Oren | President, CEO | C 轉換 | 6.0M | – | – | 6.4M | SEC |
| 2022-07-28 | 08-01 | Duey Marc | Director | A 獲配股票 | 6.0K | – | – | 158K | SEC |
| 2022-07-28 | 08-01 | Pamukcu Rifat | Director | A 獲配股票 | 6.0K | – | – | 7.9K | SEC |
| 2022-07-28 | 08-01 | Coiante Scott M | SVP, Chief Financial Officer | A 獲配股票 | 60.8K | – | – | 145K | SEC |
| 2022-07-28 | 08-01 | Seizinger Bernd R. | Director | A 獲配股票 | 6.0K | – | – | 325K | SEC |
| 2022-07-28 | 08-01 | SCHADE CHRISTIAN S | Director | A 獲配股票 | 32.4K | – | – | 259K | SEC |
| 2022-07-28 | 08-01 | Peters Richard | Director | A 獲配股票 | 6.0K | – | – | 10.6K | SEC |
| 2022-07-28 | 08-01 | Korbel Gregory Alan | SVP, Chief Operating Officer | A 獲配股票 | 24.3K | – | – | 45.8K | SEC |
| 2022-07-28 | 08-01 | HENNEMAN JOHN B III | Director | A 獲配股票 | 6.0K | – | – | 15.6K | SEC |
| 2022-07-28 | 08-01 | Grissinger Michael | Director | A 獲配股票 | 6.0K | – | – | 6.0K | SEC |
| 2022-07-28 | 08-01 | Gilad Oren | President, CEO | A 獲配股票 | 101K | – | – | 330K | SEC |
| 2022-06-03 | 06-07 | Korbel Gregory Alan | SVP, Chief Operating Officer | F 繳稅扣股 | 8.4K | 0.81 | 7K | 21.5K | SEC |
| 2022-06-03 | 06-07 | SCHADE CHRISTIAN S | Chairman & CEO | F 繳稅扣股 | 65.8K | 0.81 | 53K | 227K | SEC |
| 2022-06-03 | 06-07 | Coiante Scott M | SVP, Chief Financial Officer | F 繳稅扣股 | 35.3K | 0.81 | 29K | 84.3K | SEC |
| 2022-06-03 | 06-07 | Attar Eyal C. | SVP, Chief Medical Officer | F 繳稅扣股 | 32.7K | 0.81 | 26K | 57.2K | SEC |
| 2022-05-18 | 05-19 | SCHADE CHRISTIAN S | Chairman & CEO | P 公開市場買進 | 37.5K | 0.64 | 24K | 293K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| AIGH Capital Management LLC | 1.0M | 815K | 新進 | 新進 |
| Nantahala Capital Management, LLC | 412K | 330K | 新進 | 新進 |
| Vestal Point Capital, LP | 350K | 281K | 新進 | 新進 |
| SPHERA FUNDS MANAGEMENT LTD. | 270K | 217K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 106K | 85K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 74.9K | 60K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 58.6K | 47K | 新進 | 新進 |
| BNP PARIBAS FINANCIAL MARKETS | 45.2K | 36K | 新進 | 新進 |
| DIADEMA PARTNERS LP | 44.9K | 36K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 38.5K | 31K | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34.9K | 28K | 新進 | 新進 |
| MORGAN STANLEY | 25.8K | 21K | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 22.9K | 18K | 新進 | 新進 |
| LPL Financial LLC | 16.1K | 13K | 新進 | 新進 |
| HighTower Advisors, LLC | 13.9K | 11K | 新進 | 新進 |
| NORTHERN TRUST CORP | 13.7K | 11K | 新進 | 新進 |
| Persistent Asset Partners Ltd | 11.5K | 9K | 新進 | 新進 |
| XTX Topco Ltd | 10.6K | 8K | 新進 | 新進 |
| BlackRock, Inc. | 7.2K | 6K | 新進 | 新進 |
| Tower Research Capital LLC (TRC) | 3.6K | 3K | 新進 | 新進 |
| GROUP ONE TRADING LLC | 577 | 463.00 | 新進 | 新進 |
| BARCLAYS PLC | 473 | 379.00 | 新進 | 新進 |
| OSAIC HOLDINGS, INC. | 295 | 236.00 | 新進 | 新進 |
| WealthCollab, LLC | 158 | 127.00 | 新進 | 新進 |
| FMR LLC | 45 | 36.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 28 +6 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 28 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 2.6M · 20.5% |
| 合計季末市值 | 2.1M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 617K |
|---|---|
| 與上期比 | +11142.7% |
| 佔流通股數 | 4.90% |
| 日均成交量 | 893K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 617K | +11142.7% | 4.90% | 893K | 1.0 |
| 2026-08-14 | 5.5K | -86.6% | 0.04% | 46.7K | 1.0 |
| 2026-07-31 | 41.1K | -32.2% | 0.33% | 47.6K | 1.0 |
| 2026-07-15 | 60.6K | -22.1% | 0.48% | 74.7K | 1.0 |
| 2026-06-30 | 77.8K | +22.5% | 0.62% | 100K | 1.0 |
| 2026-06-15 | 63.5K | -46.6% | 0.50% | 126K | 1.0 |
| 2026-05-29 | 119K | -19.4% | 0.95% | 148K | 1.0 |
| 2026-05-15 | 148K | +43.2% | 1.17% | 225K | 1.0 |
| 2026-04-30 | 103K | -6.3% | 0.82% | 265K | 1.0 |
| 2026-04-15 | 110K | -82.8% | 0.87% | 410K | 1.0 |
| 2026-03-31 | 640K | +500.4% | 5.09% | 832K | 1.0 |
| 2026-03-13 | 107K | -56.6% | 0.85% | 106K | 1.0 |
| 2026-02-27 | 246K | -3.5% | 1.95% | 638K | 1.0 |
| 2026-02-13 | 255K | -1.9% | 2.03% | 564K | 1.0 |
| 2026-01-30 | 260K | +623.6% | 2.07% | 11.5M | 1.0 |
| 2026-01-15 | 35.9K | +0.9% | 0.29% | 86.4K | 1.0 |
| 2025-12-31 | 35.6K | +3.0% | 0.28% | 53.8K | 1.0 |
| 2025-12-15 | 34.6K | -41.3% | 0.27% | 101K | 1.0 |
| 2025-11-28 | 58.9K | -6.9% | 0.47% | 35.0K | 1.7 |
| 2025-11-14 | 63.3K | -9.0% | 0.50% | 96.8K | 1.0 |
| 2025-10-31 | 69.5K | +39.5% | 0.55% | 184K | 1.0 |
| 2025-10-15 | 49.8K | -42.3% | 0.40% | 67.4K | 1.0 |
| 2025-09-30 | 86.4K | +1.6% | 0.69% | 42.5K | 2.0 |
| 2025-09-15 | 85.1K | +0.7% | 0.68% | 33.5K | 2.5 |
| 2025-08-29 | 84.5K | +42.4% | 0.67% | 38.6K | 2.2 |
| 2025-08-15 | 59.3K | +5.1% | 0.47% | 67.3K | 1.0 |